Table 1.
Study (year of publication) | Assay type | Dose (mGy) | Time since exposure | Equipment | Quoted tube potential/filtration | Iodine concentration (mg I ml–1) | Foci per cell (no ICM) | Foci per cell (with ICM) | ICM associated increase in absolute foci (%) | ICM associated increase in excess foci (%) |
---|---|---|---|---|---|---|---|---|---|---|
Callisen (1979) | Lymphocyte survival | Unclear | Faxitron | 70 kV/4.2 mm Al | 3.7c | 30 | ||||
7.4c | 70 | |||||||||
18.5c | 270 | |||||||||
Hadnegy (1982) | Lymphocyte dicentrics & rings | 500 | Not stated | 250 kV/1 mm Al, 1 mm Cu | 5.6c (Urografin) | 0.064 | ||||
500 | 11.1c (Urografin) | 0.073 | ||||||||
500 | 22.2c (Urografin) | 0.119 | ||||||||
560 | 19.2c (Hexabrix) | 0.135 | ||||||||
940 | 19.2c (Hexabrix) | 0.314 | ||||||||
1250 | 19.2c (Hexabrix) | 0.465 | ||||||||
1880 | 19.2c (Hexabrix) | 1.024 | ||||||||
Jost (2009) | Lymphocyte dicentrics | 0 | Siemens Sensation 64 (CT) | n/a | 5.0 | 0.0003 | 0 | |||
25 | 120 kV | 5.0 | 0.0011 | 0.0014 | 27 | |||||
50 | 120 kV | 5.0 | 0.0021 | 0.0025 | 19 | |||||
100 | 120 kV | 5.0 | 0.0042 | 0.0059 | 40 | |||||
1000 | 120 kV | 5.0 | 0.0920 | 0.1603 | 74 | |||||
0 | n/a | 50.0 | 0.0003 | 0 | ||||||
25 | 120 kV | 50.0 | 0.0011 | 0.0082 | 645 | |||||
50 | 120 kV | 50.0 | 0.0021 | 0.0213 | 914 | |||||
100 | 120 kV | 50.0 | 0.0042 | 0.0444 | 957 | |||||
1000 | 120 kV | 50.0 | 0.0920 | 0.9094 | 888 | |||||
Jost (2009) | Lymphocyte γ-H2AX56 | 25 | Siemens Sensation 64 (CT) | 120 kV | 5.0 | 0.580 | 0.952 | 64 | ||
50 | 120 kV | 5.0 | 0.911 | 0.726 | −20 | |||||
100 | 120 kV | 5.0 | 1.503 | 1.547 | 3 | |||||
1000 | 120 kV | 5.0 | 4.697 | 6.351 | 35 | |||||
25 | 120 kV | 50.0 | 0.580 | 0.892 | 54 | |||||
50 | 120 kV | 50.0 | 0.911 | 2.232 | 145 | |||||
100 | 120 kV | 50.0 | 1.503 | 3.983 | 165 | |||||
1000 | 120 kV | 50.0 | 4.697 | 11.709 | 149 | |||||
Grudzenski (2009) | Lymphocyte γ-H2AX | 10 | 5 min | Philips PW2184 (radiography tube) | 90 kV/1 mm Al | 33.0 (Iopromide) | 0.217a,d | 0.359a,d | 66 | |
30 m | 0.133a,d | 0.266a,d | 100 | |||||||
2.5 h | 0.080a,d | 0.190a,d | 138 | |||||||
5 h | 0.032a,d | 0.109ad | 241 | |||||||
500 | 5 min | Philips PW2184 (radiography tube) | 90 kV/1 mm Al | 33.0 (Iopromide) | 9.27a,d | 15.00a,d | 62 | |||
30 min | 5.51a,d | 9.90a,d | 80 | |||||||
2.5 h | 3.20 a,d | 6.58a,d | 106 | |||||||
5 h | 1.56a,d | 3.29a,d | 111 | |||||||
500 | 5 min | 662 keV γ source (Cs-137) | n/a | 33.0 (Iopromide) | 8.34 a,d | 7.62ad | 10 | |||
30 min | 5.77ad | 5.51a,d | 5 | |||||||
2.5 h | 4.08a,d | 4.52ad | −10 | |||||||
5 h | 2.00a,d | 1.92a,d | 4 | |||||||
Grudzenski (2009) | Fibroblast γ-H2AX | 1500 | 30 min | Philips PW2184 (radiography tube) | 90 kV/1 mm Al | 33.0 (Iopromide) | 26.7a,d | 36.5a,d | 37 | |
2.5 h | 10.6a,d | 18.6a,d | 75 | |||||||
5 h | 5.9a,d | 8.4a,d | 42 | |||||||
Fibroblast γ-H2AX | 1500 | 30 min | 90 kV/1 mm Al | 33.0 (Iomeprol) | 26.7a,d | 37.2a,d | 39 | |||
2.5 h | 10.6a,d | 16.9a,d | 59 | |||||||
5 h | 5.9a,d | 8.4a,d | 42 | |||||||
Fibroblast 53bp1 | 1500 | 30 min | 90 kV/1 mm Al | 33.0 (Iopromide) | 26.5a,d | 34.8a,d | 31 | |||
2.5 h | 10.9a,d | 17.2a,d | 58 | |||||||
5 h | 5.9a,d | 9.5a,d | 61 | |||||||
Fibroblast 53bp1 | 1500 | 30 min | 90 kV/1 mm Al | 33.0 (Iomeprol) | 26.5a,d | 35.9a,d | 36 | |||
2.5 h | 10.9a,d | 17.2a,d | 58 | |||||||
5 h | 5.9a,d | 10.2a,d | 73 | |||||||
Pathe (2011) | Lymphocyte γ-H2AX | 0 | Immediate | n/a | n/a | 37.0c (Iopromide 370) | 0.18 | 0.12 | −33 | |
30 min | 0.05 | 0.10 | 100 | |||||||
1 h | 0.04 | 0.11 | 175 | |||||||
2 h | 0.05 | 0.10 | 100 | |||||||
24 h | 0.08 | 0.03 | −63 | |||||||
20 | Immediate | Siemens Multix M (radiography) | 102 kV | 0.55 | 1.29 | 135 | 216 | |||
30 min | 0.63 | 1.23 | 95 | 95 | ||||||
1 h | 0.51 | 0.9 | 76 | 68 | ||||||
2 h | 0.53 | 0.81 | 53 | 48 | ||||||
24 h | 0.28 | 0.3 | 7 | 35 | ||||||
100 | Immediate | 102 kV | 1.57 | 2.98 | 90 | 106 | ||||
30 min | 1.92 | 3.18 | 66 | 65 | ||||||
1 h | 1.50 | 2.39 | 59 | 56 | ||||||
2 h | 1.05 | 2.11 | 101 | 101 | ||||||
24 h | 0.42 | 0.36 | −14 | −3 | ||||||
200 | Immediate | 102 kV | 3.73 | 4.31 | 16 | 18 | ||||
30 min | 3.24 | 4.79 | 48 | 47 | ||||||
1 h | 2.38 | 3.38 | 42 | 40 | ||||||
2 h | 2.37 | 2.59 | 9 | 7 | ||||||
24 h | 0.52 | 0.36 | −31 | −25 | ||||||
1000 | Immediate | 102 kV | 6.10 | 9.09 | 49 | 52 | ||||
30 min | 6.32 | 8.49 | 34 | 34 | ||||||
1 h | 4.65 | 5.94 | 28 | 26 | ||||||
2 h | 4.56 | 5.01 | 10 | 9 | ||||||
24 h | 1.26 | 1.99 | 58 | 66 | ||||||
Beels (2012) | Lymphocyte γ-H2AX | 5 | Philips MG420 generator, MCN420 tube | 100 kV/2 mm Al | 5.0 | 0.73d | 0.71d | −4d | ||
10.0 | 0.73d | 0.80d | 9d | |||||||
20.0 | 0.73d | 0.70d | −5d | |||||||
10 | 5.0 | 0.96d | 1.13d | 16d | ||||||
10.0 | 0.96d | 0.89d | −8d | |||||||
20.0 | 0.96d | 0.89d | −8d | |||||||
50 | 5.0 | 1.41d | 1.51d | 6d | ||||||
10.0 | 1.41d | 1.55d | 9d | |||||||
20.0 | 1.41d | 1.51d | 6d | |||||||
Deinzer (2014) | Lymphocyte γ-H2AX | 20 | Siemens Axiom Multix MT | 102 kV | 7.5 | 0.240 | 0.313b | 30 | ||
15.0 | 0.240 | 0.379b | 58 | |||||||
500 | 7.5 | 3.581 | 3.956b | 10 | ||||||
15.0 | 3.581 | 4.926b | 38 | |||||||
Gould (2015) | Lymphocyte γ-H2AX | 70 | Carestream DRX-Evolution (radiography) | 120 kV | 15.0 | 44 | ||||
17.5 | 82 | |||||||||
30.0 | 89 | |||||||||
35.0 | 111 | |||||||||
45.0 | 89 | |||||||||
52.5 | 99 | |||||||||
Gould (2015) | Lymphocyte γ-H2AX | 140 | Carestream DRX-Evolution (radiography) | 120 kV | 15.0 | 42 | ||||
17.5 | 50 | |||||||||
30.0 | 75 | |||||||||
35.0 | 64 | |||||||||
45.0 | 86 | |||||||||
52.5 | 76 | |||||||||
250 | 120 kV | 15.0 | 14 | |||||||
17.5 | 31 | |||||||||
30.0 | 35 | |||||||||
35.0 | 35 | |||||||||
45.0 | 49 | |||||||||
52.5 | 49 | |||||||||
450 | 120 kV | 15.0 | 11 | |||||||
17.5 | 36 | |||||||||
30.0 | 25 | |||||||||
35.0 | 48 | |||||||||
45.0 | 33 | |||||||||
52.5 | 59 |
Foci numbers in excess of baseline levels.
Mean of 7 contrast media products.
Calculated by current authors based on data quoted in original paper.
Data not quoted numerically. Read from figure(s).